Iteos Therapeutics
Records under this name other than the patents Iteos Therapeutics holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 7 of 7 · Back to Iteos Therapeutics
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,544,095 | Novel 3-Indol Substituted Derivatives, Pharmaceutical Compositions and Methods for Use Formerly held In force · High confidence | In force | High confidence | |
| US 9,949,951 | Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors Lapsed on the fee record Ended Apr 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 24, 2026 | From the USPTO record |
| US 10,945,994 | Combinations Comprising a PYRROLIDINE-2,5-Dione IDO1 Inhibitor and an Anti-Body Lapsed on the fee record Ended Mar 16, 2025 · High confidence | Lapsed on the fee record | Ended Mar 16, 2025 | High confidence |
| US 10,398,679 | Treatment method utilizing pyrrolidine-2, 5-dione derivatives as IDO1 inhibitors Lapsed on the fee record Ended Sep 3, 2023 · From the USPTO record | Lapsed on the fee record | Ended Sep 3, 2023 | From the USPTO record |
| US 9,873,690 | Novel 3-Indol Substituted Derivatives, Pharmaceutical Compositions and Methods for Use Lapsed on the fee record Ended Jan 23, 2022 · High confidence | Lapsed on the fee record | Ended Jan 23, 2022 | High confidence |
| US 9,758,505 | 3-(indol-3-yl)-pyridine derivatives, pharmaceutical compositions and methods for use Lapsed on the fee record Ended Sep 12, 2021 · From the USPTO record | Lapsed on the fee record | Ended Sep 12, 2021 | From the USPTO record |
| US 9,126,984 | 4-(indol-3-yl)-pyrazole derivatives, pharmaceutical compositions and methods for use Formerly held Lapsed on the fee record Ended Sep 8, 2019 · From the USPTO record | Lapsed on the fee record | Ended Sep 8, 2019 | From the USPTO record |